S7C Stock Overview
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products to patients in the Danish and European markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Stenocare A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 0.28 |
| 52 Week High | DKK 1.03 |
| 52 Week Low | DKK 0.14 |
| Beta | 0.31 |
| 11 Month Change | 39.90% |
| 3 Month Change | -17.92% |
| 1 Year Change | -26.23% |
| 33 Year Change | -79.06% |
| 5 Year Change | n/a |
| Change since IPO | -88.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| S7C | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 70.6% | -1.2% | -0.02% |
| 1Y | -26.2% | -20.1% | 8.2% |
Return vs Industry: S7C underperformed the German Pharmaceuticals industry which returned -20.1% over the past year.
Return vs Market: S7C underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| S7C volatility | |
|---|---|
| S7C Average Weekly Movement | 19.9% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: S7C's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: S7C's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Thomas Schnegelsberg | www.stenocare.dk |
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products to patients in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
Stenocare A/S Fundamentals Summary
| S7C fundamental statistics | |
|---|---|
| Market cap | €6.00m |
| Earnings (TTM) | -€2.20m |
| Revenue (TTM) | €299.39k |
20.0x
P/S Ratio-2.7x
P/E RatioIs S7C overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S7C income statement (TTM) | |
|---|---|
| Revenue | DKK 2.23m |
| Cost of Revenue | DKK 7.85m |
| Gross Profit | -DKK 5.62m |
| Other Expenses | DKK 10.79m |
| Earnings | -DKK 16.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | -0.82 |
| Gross Margin | -251.53% |
| Net Profit Margin | -734.67% |
| Debt/Equity Ratio | 14.9% |
How did S7C perform over the long term?
See historical performance and comparison